Experts say the top challenge for the managed care pharmaceutical industry is rising costs.
Care and sustainability, according to Managed Healthcare Executive’s (MHE) second managed care pharmacy survey, are both threatened by increasing drug costs and the surging demand for specialty drugs.
MHE’s survey team spoke with 200-plus industry insiders for the survey, which was conducted earlier this year.
MHE, after consulting research conducted by the Alliance of Community Health Plans, says a 15- to 20-percent surge in demand for specialty drugs is likely just around the corner. Experts took into account population growth, product pricing and patient choice.